Effect of Pulmonary Rehabilitation on Functional Exercise Capacity and Hypoxemia in Patients with Interstitial Lung Diseases: a retrospective study

2018 ◽  
Author(s):  
Salvatore Fuschillo ◽  
Alberto De Felice ◽  
Carlo Gaudiosi ◽  
Michele Martucci ◽  
Mauro Maniscalco
Keyword(s):  
Retrospective Study ◽  
Exercise Capacity ◽  
Pulmonary Rehabilitation ◽  
Lung Diseases ◽  
Interstitial Lung Diseases ◽  
Functional Exercise ◽  
Functional Exercise Capacity

scholarly journals Survival after pulmonary rehabilitation in patients with COPD: impact of functional exercise capacity and its changes

2016 ◽  
Vol Volume 11 ◽  
pp. 2671-2679 ◽  
Author(s):  
Carlos Camillo ◽  
Daniel Langer ◽  
Christian Osadnik ◽  
Lisa Pancini ◽  
Heleen Demeyer ◽  
...  
Keyword(s):  
Exercise Capacity ◽  
Pulmonary Rehabilitation ◽  
Functional Exercise ◽  
Functional Exercise Capacity ◽  
Copd Impact

scholarly journals Clinical effectiveness and components of Home-pulmonary rehabilitation for people with chronic respiratory diseases: a systematic review protocol

BMJ Open ◽  
2021 ◽  
Vol 11 (10) ◽  
pp. e050362
Author(s):  
Md Nazim Uzzaman ◽  
Soo Chin Chan ◽  
Ranita Hisham Shunmugam ◽  
Julia Patrick Engkasan ◽  
Dhiraj Agarwal ◽  
...  
Keyword(s):  
Usual Care ◽  
Exercise Capacity ◽  
Pulmonary Rehabilitation ◽  
Respiratory Diseases ◽  
Clinical Effectiveness ◽  
Published Data ◽  
Chronic Respiratory Diseases ◽  
Functional Exercise ◽  
Functional Exercise Capacity

IntroductionChronic respiratory diseases (CRDs) are common and disabling conditions that can result in social isolation and economic hardship for patients and their families. Pulmonary rehabilitation (PR) improves functional exercise capacity and health-related quality of life (HRQoL) but practical barriers to attending centre-based sessions or the need for infection control limits accessibility. Home-PR offers a potential solution that may improve access. We aim to systematically review the clinical effectiveness, completion rates and components of Home-PR for people with CRDs compared with Centre-PR or Usual care.Methods and analysisWe will search PubMed, CINAHL, Cochrane, EMBASE, PeDRO and PsycInfo from January 1990 to date using a PICOS search strategy (Population: adults with CRDs; Intervention: Home-PR; Comparator: Centre-PR/Usual care; Outcomes: functional exercise capacity and HRQoL; Setting: any setting). The strategy is to search for ‘Chronic Respiratory Disease’ AND ‘Pulmonary Rehabilitation’ AND ‘Home-PR’, and identify relevant randomised controlled trials and controlled clinical trials. Six reviewers working in pairs will independently screen articles for eligibility and extract data from those fulfilling the inclusion criteria. We will use the Cochrane risk-of-bias tool and Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to rate the quality of evidence. We will perform meta-analysis or narrative synthesis as appropriate to answer our three research questions: (1) what is the effectiveness of Home-PR compared with Centre-PR or Usual care? (2) what components are used in effective Home-PR studies? and (3) what is the completion rate of Home-PR compared with Centre-PR?Ethics and disseminationResearch ethics approval is not required since the study will review only published data. The findings will be disseminated through publication in a peer-reviewed journal and presentation in conferences.PROSPERO registration numberCRD42020220137.

scholarly journals Validity of the 6-Minute Walk Test in Patients with End-Stage Lung Diseases Wearing an Oronasal Surgical Mask in Times of the COVID-19 Pandemic

Respiration ◽  
2021 ◽  
pp. 1-6
Author(s):  
Isabell Anna Just ◽  
Felix Schoenrath ◽  
Philipp Passinger ◽  
Julia Stein ◽  
Dagmar Kemper ◽  
...  
Keyword(s):  
Exercise Capacity ◽  
Lung Diseases ◽  
Chronic Obstructive ◽  
Walk Test ◽  
Functional Exercise ◽  
Functional Exercise Capacity ◽  
End Stage ◽  
6 Minute Walk Test ◽  
The Impact ◽  
Minute Walk

<b><i>Background and Objectives:</i></b> The 6-minute walk test (6MWT), as a clinical assessment tool for functional exercise capacity, is an integral component of lung allocation scores (LASs). In times of the coronavirus disease (COVID-19) pandemic, patients underwent 6MWTs wearing a surgical mask in ambulatory care. We investigated the impact of wearing a mask on 6-minute walk distances (6MWDs). <b><i>Method:</i></b> 6MWDs of 64 patients with end-stage lung diseases wearing an oronasal surgical mask were retrospectively compared to previously investigated 6MWDs of the same cohort, in a pre-COVID-19 pandemic era, without wearing a mask. Four patients were excluded due to a primary vascular disease, 29 patients due to clinically unstable pulmonary functions, and 1 patient due to a psychiatric disorder. <b><i>Results:</i></b> The median age of the patients included was 55 (46–58) years; 15 (48%) were male. Ten (32.2%) were on the Eurotransplant lung transplant waiting list with a median LAS of 34.3 (31.9–36.2). Twenty (64.5%) patients had chronic obstructive pulmonary diseases, 7 (22.6%) had interstitial lung diseases, and 4 (12.9%) had other end-stage lung diseases. The mean 6MWD without versus with wearing a mask was 306.9 (101.9) versus 305.7 (103.8) m, with a mean difference of −1.19 m (95% confidence interval −13.4 to 11.03). The observed difference is statistically equivalent to zero (<i>p</i> &#x3c; 0.001). No significant differences in 6MWDs were observed between the clinical groups. <b><i>Conclusion:</i></b> Wearing an oronasal surgical mask did not affect the 6MWDs of patients with advanced lung diseases. Therefore, a masked 6MWT appears to provide a reliable examination of functional exercise capacity in this cohort.

Effectiveness of Repeated Courses of Pulmonary Rehabilitation on Functional Exercise Capacity in Patients With COPD

2015 ◽  
Vol 35 (4) ◽  
pp. 272-277 ◽  
Author(s):  
Ali Atabaki ◽  
Jonathan Fine ◽  
Margaret Haggerty ◽  
Corliss Marolda ◽  
Dorothy Wakefield ◽  
...  
Keyword(s):  
Exercise Capacity ◽  
Pulmonary Rehabilitation ◽  
Functional Exercise ◽  
Functional Exercise Capacity

scholarly journals The Influence of Comorbidities on Outcomes of Pulmonary Rehabilitation Programs in Patients with COPD: A Systematic Review

2013 ◽  
Vol 2013 ◽  
pp. 1-8 ◽  
Author(s):  
Miek Hornikx ◽  
Hans Van Remoortel ◽  
Heleen Demeyer ◽  
Carlos Augusto Marcal Camillo ◽  
Marc Decramer ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Cardiovascular Disease ◽  
Exercise Capacity ◽  
Pulmonary Rehabilitation ◽  
Chronic Obstructive ◽  
Rehabilitation Outcomes ◽  
Rehabilitation Programs ◽  
Functional Exercise ◽  
Functional Exercise Capacity

Introduction. Chronic obstructive pulmonary disease (COPD) is associated with comorbidities such as cardiovascular disease, metabolic disease, osteoporosis, and anxiety and/or depression. Although pulmonary rehabilitation programs are proven to be beneficial in patients with COPD, it is unclear whether comorbidities influence pulmonary rehabilitation outcomes. The aim of the present review was to investigate to what extent the presence of comorbidities can affect pulmonary rehabilitation outcomes.Methods. The systematic literature search (Pubmed, EMBASE, and PEDro) resulted in 4 articles meeting the inclusion criteria. The odds ratios (95% confidence intervals) of the logistic regression analyses, with comorbidities as independent variables and pulmonary rehabilitation outcomes (dyspnea, functional exercise capacity, and quality of life) as dependent variables, were used for data extraction.Results. Patients with anxiety and/or depression less likely improve in dyspnea. Osteoporosis is associated with less improvements in functional exercise capacity, while cardiovascular disease does not seem to negatively impact on this outcome. Patients with cardiovascular comorbidity will experience less positive changes in quality of life.Conclusion. Evidence from literature suggests that comorbidities can have a negative influence on pulmonary rehabilitation outcomes. Screening for comorbidities in pulmonary rehabilitation settings seems useful to readdress the right patients for individually tailored pulmonary rehabilitation.

scholarly journals Trajectories of functional exercise capacity in patients undergoing pulmonary rehabilitation

2019 ◽  
Vol Volume 14 ◽  
pp. 863-870 ◽  
Author(s):  
Chien-Tzu Lee ◽  
Ping-Lun Hsieh ◽  
Meng-Yueh Chien ◽  
Jung-Yien Chien ◽  
Huey-Dong Wu ◽  
...  
Keyword(s):  
Exercise Capacity ◽  
Pulmonary Rehabilitation ◽  
Functional Exercise ◽  
Functional Exercise Capacity

scholarly journals Efficacy of an mHealth intervention to stimulate physical activity in COPD patients after pulmonary rehabilitation

2016 ◽  
Vol 48 (4) ◽  
pp. 1019-1029 ◽  
Author(s):  
Sigrid N.W. Vorrink ◽  
Helianthe S.M. Kort ◽  
Thierry Troosters ◽  
Pieter Zanen ◽  
Jan-Willem J. Lammers
Keyword(s):  
Physical Activity ◽  
Lung Function ◽  
Usual Care ◽  
Exercise Capacity ◽  
Pulmonary Rehabilitation ◽  
Mhealth Intervention ◽  
Positive Effects ◽  
Copd Patients ◽  
Functional Exercise ◽  
Functional Exercise Capacity

Physical inactivity in patients with chronic obstructive pulmonary disease (COPD) is associated with poor health status and increased disease burden. The present study aims to test the efficacy of a previously developed mobile (m)Health intervention to improve or maintain physical activity in patients with COPD after pulmonary rehabilitation.A randomised controlled trial was performed in 32 physiotherapy practices in the Netherlands. COPD patients were randomised into intervention or usual care groups. The intervention consisted of a smartphone application for the patients and a monitoring website for the physiotherapists. Measurements were performed at 0, 3, 6 and 12 months. Physical activity, functional exercise capacity, lung function, health-related quality of life and body mass index were assessed.157 patients started the study and 121 completed it. There were no significant positive effects of the intervention on physical activity (at 0 months: intervention 5824±3418 steps per weekday, usual care 5717±2870 steps per weekday; at 12 months: intervention 4819±2526 steps per weekday, usual care 4950±2634 steps per weekday; p=0.811) or on the secondary end-points. There was a significant decrease over time in physical activity (p<0.001), lung function (p<0.001) and mastery (p=0.017), but not in functional exercise capacity (p=0.585).Although functional exercise capacity did not deteriorate, our mHealth intervention did not improve or maintain physical activity in patients with COPD after a period of pulmonary rehabilitation.

scholarly journals Impact of Pulmonary Rehabilitation Services in Patients with Different Lung Diseases

2022 ◽  
Vol 11 (2) ◽  
pp. 407
Author(s):  
Diana C. Sanchez-Ramirez
Keyword(s):  
Lung Cancer ◽  
Exercise Capacity ◽  
Self Efficacy ◽  
Pulmonary Rehabilitation ◽  
Lung Diseases ◽  
Interstitial Lung Diseases ◽  
Chronic Obstructive ◽  
Publicly Funded ◽  
Obstructive Pulmonary Disease ◽  
The Impact

Background: the effect of pulmonary rehabilitation (PR) services, beyond research contexts, on patients with lung diseases other than COPD requires further study. Objectives: to (i) assess the impact of a publicly funded PR on patients’ exercise capacity, self-efficacy, and health-related quality of life (HRQoL), and (ii) explore whether the effects vary across lung diseases. Methods: this retrospective pre–post study analyzed data from the Winnipeg Regional Health Authority PR program between 2016 and 2019. Results: 682 patients completed the full PR program. Pooled analyses found significant improvements in the patients’ exercise capacity (six-minute walk test (6MWT) (13.6%), fatigue (10.3%), and dyspnea (6.4%)), Self-Efficacy for Managing Chronic Disease 6-Item Scale (SEMCD6) (11.6%), and HRQoL (Clinical COPD Questionnaire (CCQ) (18.5%) and St George’s Respiratory Questionnaire (SGRQ) (10.9%)). The analyses conducted on sub-groups of patients with chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis, interstitial lung diseases (ILDs), other restrictive lung diseases (e.g., obesity, pleural effusion, etc.), lung cancer, and pulmonary hypertension (PH) indicated that, except for patients with PH, all the patients improved in the 6MWT. Fatigue decreased in patients with COPD, ILDs, and other restrictive lung diseases. Dyspnea decreased in patients with COPD, asthma, and lung cancer. SEMCD6 scores increased in COPD, ILDs and PH patients. CCQ scores decreased in all lung diseases, except lung cancer and PH. SGRQ scores only decreased in patients with COPD. Conclusion: PR services had a significant impact on patients with different lung diseases. Therefore, publicly funded PR should be available as a critical component in the management of patients with these diseases.

Sign in / Sign up

Export Citation Format

Share Document